All patients with mechanical heart valves need long term treatment with anticoagulant drugs to prevent thromboembolism. Because the use of these drugs in pregnancy increases the risk of abortion or fetal damage management of pregnant women with valve prostheses is still controversial. Women with artificial heart valves may even be advised against pregnancy because of the "serious risks to both mother and child". ' A hypercoagulable state exists in pregnancy when concentrations of clotting factors, platelet turnover, and viscosity are increased and fibrinolysis is diminished. These changes increase the risk of prosthetic valve thrombosis. 2 Whenever possible childbearing should be completed before valve replacement. In general, patients with severe mitral or aortic regurgitation tolerate pregnancy well probably because of the beneficial effects of vascular dilatation; the slight increase in heart rate seen in most As a compromise it has been suggested that the coumarins should be replaced by subcutaneous heparin during the first trimester and the last two weeks of pregnancy. An early report by Salazar et al of the use of heparin in a fixed dose of 5000 units every 12 hours was encouraging.4 More recently, his group examined the risk of embryopathy when coumarins were given throughout pregnancy, when heparin was given from the 6th to 12th week, and when heparin was started after the seventh week. The high incidence of spontaneous abortion was similar with all three regimens, but two women receiving subcutaneous heparin during the first trimester suffered massive valve thombosis and in another the valve thrombosed during the last two weeks of pregnancy after the patient had been transferred back to heparin.
Children were examined for signs of embryopathy by a clinical geneticist and this probably explains why the reported incidence was higher than in other reports.'2 14 No abnormalities were seen in any of the children born after heparin had been used from the sixth week but two out of eight of the liveborn infants resulting from the 12 pregnancies treated with heparin between the 7th and 12th weeks had suggestive minor facial defects and two out of 27 children resulting from 37 pregnancies in women receiving coumarin drugs throughout pregnancy had features of embryopathy. No cases of central nervous system defects, dwarfism, or epiphyseal stippling were seen, however, so none of these children was seriously affected. Chen saw no cases of embryopathy among The use of anticoagulant doses of heparin may reduce the risk of valve thrombosis (though this has still to be shown), but it carries a substantial risk of both maternal haemorrhage and spontaneous abortion. Moreover, it can also cause thrombocytopenia, alopecia, and osteoporosis. 1718
Intravenous heparin has been widely used in hospital in the last two weeks of pregnancy without adverse effects. It has the virtue that both the mother and the fetus can be continuously observed. The effect of warfarin on the baby must be assumed to persist for seven to ten days after warfarin is stopped and the baby should be given vitamin K. Breast feeding is not contraindicted. '9 If the mother is admitted in premature labour while still on warfarin she should be given fresh frozen plasma before caesarean section. The effects of heparin can be temporarily reversed with protamine, and warfarin treatment can be resumed immediately after delivery.
It is uncertain whether the teratogenic effect of coumarin derivatives is the result of their chemical structure or of the anticoagulant effect exerted at a critical period of development of cartilagenous bone. The lack of information about the safety of phenindione during the first trimester may be attributable to its infrequent use rather than to its greater safety. Nevertheless, at Hammersmith Hospital we have for some years transferred young women to phenindione in pregnancy and have had no embryopathies and no compromised babies. 20 Although both Hall and Salazar concluded that women of childbearing age with artificial valves should be advised not to attempt pregnancy, we are more optimistic2 22 and believe that the danger to the mother is very small6; that the chance of a successful outcome is good; and that most unsuccessful pregnancies are miscarried so that the risk of a liveborn malformed baby is small. Whenever possible, childbearing should be completed before valve replacement, but when this is not possible, mechanical valves should be chosen and currently phenindione is the preferred anticoagulant with transfer to intravenous heparin in hospital during the last two weeks of pregnancy.
